Objective Delayed-release metformin (Met DR) is formulated to deliver the drug to the lower bowel to leverage the gut-based mechanisms of metformin action with lower plasma exposure. Met DR was ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Buformin, another biguanide, is not available in the United States. The complex of mechanisms of action of metformin is multifaceted but appears to include delayed glucose absorption, increased ...

A major new trial has begun that will see scientists explore if a chemical mostly found in red grapes and products made from the grapes like wine can help prevent bowel cancer. The study called ...

This indicates that metformin doesn't just target tumor cells but also influences the surrounding immune environment, providing a dual mechanism of action. This ability to modulate immune ...

This indicates that metformin doesn’t just target tumor cells but also influences the surrounding immune environment, providing a dual mechanism of action. This ability to modulate immune ...

AstraZeneca and Eccogene revealed promising trial data on ECC5004, an oral GLP-1 receptor agonist for obesity, showing safety ...

This is vigilant monthly action by CSDCO brings down the percentage ... Oxytocin by Pushkar Pharma, Metformin by Swiss Biotech Parentarels, Calcium 500 mg and Vitamin D3 250 IU Tablets by Life ...